CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Myometrial Samplingprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03752021
NCT03752021N/ACompleted

The Endocannabinoid System in Human Gestational Tissues in Labor

Wake Forest University Health Sciences·observational·Posted Nov 23, 2018·Updated Aug 15, 2019

In Brief

An observational study evaluating Myometrial Sampling for Labor. Completed, enrolled 20 participants across 2 sites.

Detailed Summary

The purpose of this research study is to determine if the endocannabinoid (a biological system) plays a role in the labor process.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLabor
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedNov 23, 2018
Enrollment StartJan 25, 2019
Primary CompletionJul 1, 2019
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 7.6 years ago

Interventions

Myometrial Samplingprocedure

A myometrial sample will be obtained at the time of cesarean delivery. Sample will be obtained from the superior edge of the existing lower uterine segment incision and will be 2 inches in length and 0.5 inches in width. The uterine incision will be repaired in a standard two-layer closure. If a classical cesarean (vertical) uterine incision is deemed necessary and is performed by the surgical team, a sample of the same size will be taken parallel to the incision at the existing edge. The classical uterine incision will be closed utilizing the standard layered technique. Placenta and gestational membrane tissue will be obtained after placental delivery. The entire placenta and attached gestational membranes will be collected if not being sent for pathologic review